2017-01-12,These 5 Stocks Under $10 Could Explode Higher Soon
2016-05-26,These 5 Stocks Under $10 Are About to Soar Higher
2015-11-17,Opexa Therapeutics Chosen As One Of The Top Autoimmune Therapy Projects To Watch
2015-11-10,Opexa Therapeutics Announces Supportive Preclinical Study Results For Its Neuromyelitis Optica (NMO) Program
2015-11-10,Opexa Therapeutics Reports Third Quarter 2015 Financial Results And Provides Corporate Update
2015-11-06,Opexa Therapeutics Announces News Release Schedule For Third Quarter 2015 Financial Results
2015-10-19,Opexa Therapeutics To Host Analyst And Investor Event On November 10 In New York
2015-10-15,Opexa Therapeutics Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
2015-10-13,Opexa Therapeutics To Present At BIO Investor Forum
2015-10-06,Opexa Announces Granting Of New T-cell Patents Covering Tcelna®; Patent Estate Increases To 160 Issued Patents
2015-10-01,5 Stocks Under $10 Set to Soar
2015-09-28,Opexa Announces Reverse Stock Split
2015-09-01,Opexa Secures Private Funding For Its NMO Orphan Development Program, Including Planned Phase I/II Clinical Study
2015-08-28,Opexa Therapeutics To Present At September Conferences
2015-08-12,Opexa Therapeutics Reports Second Quarter 2015 Financial Results And Provides Corporate Update
2015-08-03,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Second Quarter 2015 Financial Results
2015-06-11,Opexa Therapeutics CEO To Present At BIO 2015 International Convention
2015-06-09,Opexa Hires Experienced Pharmaceutical Executive As Vice President Of Business Development
2015-06-08,Trade-Ideas: Opexa Therapeutics (OPXA) Is Today's Weak On High Relative Volume Stock
2015-05-29,Today's Weak On High Volume Stock: Opexa Therapeutics (OPXA)
2015-05-21,Opexa Therapeutics To Present At The 2015 Marcum Microcap Conference
2015-05-13,Opexa Therapeutics CEO Invited To Participate In Multiple May Conferences
2015-05-12,Opexa Therapeutics Reports First Quarter 2015 Financial Results And Provides Corporate Update
2015-05-11,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss First Quarter 2015 Financial Results
2015-04-20,Opexa Therapeutics Invited To Present Biomarker Data From NMO Patients At The American Academy Of Neurology (AAN) 2015 Annual Meeting
2015-04-09,Opexa Therapeutics, Inc. Announces Completion Of Rights Offering
2015-04-06,Opexa Therapeutics Reminds Shareholders That Rights Offering Expires On April 8, 2015 At 5:00 PM ET
2015-03-10,Opexa Therapeutics Reminds Shareholders That Rights Offering Ownership Date And Time Is Tuesday, March 10, 2015 At 4:00 PM ET
2015-03-09,Opexa Amends Agreement With Merck Serono And Receives Additional $3 Million Payment To Support Ongoing Development Of Tcelna® For Multiple Sclerosis
2015-02-25,Opexa Therapeutics, Inc. Announces Record Date And Subscription Price For Rights Offering
2015-02-23,Opexa Therapeutics Reports Year End 2014 Financial Results And Provides Corporate Update
2015-01-28,Opexa Therapeutics, Inc. Files Registration Statement For Rights Offering
2014-11-18,Opexa Therapeutics Selected As One Of The "Top 10 Advanced Therapy Projects To Watch"
2014-11-11,Opexa Therapeutics CEO Invited To Join Personalized Medicine Panel At New York CEO Conference
2014-11-06,Opexa Therapeutics Reports Third Quarter 2014 Financial Results And Provides Corporate Update
2014-11-05,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Third Quarter 2014 Financial Results
2014-10-22,Opexa Therapeutics Supports National Multiple Sclerosis Society And Walk MS
2014-10-20,Opexa Therapeutics To Present At Cleveland Clinic’s 12th Annual Medical Innovation Summit
2014-10-02,Opexa Therapeutics Announces Analyst And Investor Event
2014-09-29,Opexa Strengthens Patent Portfolio With Expansion Into B-cell Diseases And Announces Allowance Of 98th T-cell Patent
2014-09-16,Opexa Therapeutics, Inc. Announces Termination Of Public Offering Of Common Stock
2014-09-15,Opexa Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock
2014-09-08,Opexa Therapeutics To Target Rare Disease Neuromyelitis Optica (NMO) As Next Development Program
2014-09-02,Opexa Therapeutics To Present At September Conferences
2014-08-14,Opexa Therapeutics Reports Second Quarter 2014 Financial Results And Provides Corporate Update
2014-08-11,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Second Quarter 2014 Financial Results
2014-07-07,Ratings Changes Today
2014-06-30,Opexa Therapeutics Joins Russell Microcap Index
2014-05-14,Opexa Therapeutics Reports First Quarter 2014 Financial Results And Provides Corporate Update
2014-05-13,Opexa Reaches Enrollment Target In Phase IIb Trial Of Personalized Immunotherapy For Secondary Progressive Multiple Sclerosis
2014-05-12,Opexa Therapeutics Announces News Release And Conference Call To Discuss First Quarter 2014 Financial Results
2014-04-22,Opexa Therapeutics To Attend The American Academy Of Neurology Annual Meeting
2014-03-21,Lawsuits, Clinical Studies, Financial Results, And Stock Movements - Analyst Notes On Idenix, BG Medicine, Progenics, Omeros, And Opexa
2014-03-20,Opexa Therapeutics Appoints Prof. Hans-Peter Hartung And Timothy Barabe To The Board Of Directors
2014-02-27,Opexa Therapeutics Reports Year End 2013 Financial Results And Provides Corporate Update
2014-02-26,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Year End 2013 Financial Results
2014-02-11,Opexa Therapeutics CEO To Present At The 2014 Leerink Global Healthcare Conference
2014-01-29,Opexa Therapeutics To Present At The 16th Annual BIO CEO &amp; Investor Conference
2014-01-23,Opexa Therapeutics Chief Scientific Officer Invited As Guest Speaker At The Phacilitate Cell &amp; Gene Therapy Forum
2013-12-23,Opexa Therapeutics, Inc. Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters&#8217;&#160;Option&#160;to Purchase Additional Shares
2013-12-17,Opexa Therapeutics, Inc. Announces Pricing Of Public Offering Of&#160;Common&#160;Stock
2013-12-17,Opexa Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock
2013-12-16,Opexa Therapeutics Provides MS Trial Enrollment Update; 70% Of Patients Enrolled
2013-11-12,Opexa Therapeutics Selected As A &#8220;Top 10 Advanced Therapy Projects To Watch&#8221;
2013-11-08,Opexa CEO Invited To Join Personalized Medicine Panel At New York CEO Conference
2013-11-07,Opexa Therapeutics Reports Third Quarter 2013 Financial Results And Provides Corporate Update
2013-11-06,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Third Quarter 2013 Financial Results
2013-11-06,3 Health Care Stocks Under $10 Making Big Moves
2013-10-23,Opexa Therapeutics Supports National Multiple Sclerosis Society As A Corporate Sponsor Of Walk MS
2013-10-21,Opexa Therapeutics Immune Monitoring Program Featured In Neurology Reviews
2013-10-08,Faruqi &amp; Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
2013-10-07,Opexa Therapeutics&#8217; CEO Featured In Leading Life Science Publication
2013-10-02,Opexa Therapeutics&#8217; Therapy For Multiple Sclerosis Featured In FOX Television News Story
2013-09-30,Opexa CEO Invited Panelist At 9th Annual Burrill Personalized Medicine Meeting
2013-09-27,Opexa To Present At The Aegis Capital Corp. 2013 Healthcare Conference
2013-09-25,Opexa Announces Conversion Of All Convertible Secured Promissory Notes Into&#160;Common&#160;Stock
2013-09-05,Opexa To Present At The Rodman &amp; Renshaw 15th Annual Global Investment Conference
2013-09-04,Opexa Therapeutics, Inc. Announces Closing Of Partial Exercise Of Underwriters&#8217; Option To Purchase Additional Shares Of Common Stock
2013-08-27,Opexa Announces Issuance Of 50th Patent For T-cell Immunotherapy Platform
2013-08-14,Opexa Therapeutics Reports Second Quarter 2013 Financial Results And Provides Corporate Update
2013-08-13,Opexa Therapeutics Announces News Release And Conference Call Schedule To Discuss Second Quarter 2013 Financial Results
2013-08-13,Opexa Therapeutics, Inc. Announces Closing Of Public Offering Of Common Stock
2013-08-07,Opexa Therapeutics, Inc. Announces Pricing Of Public Offering Of&#160;Common&#160;Stock
2013-06-07,5 Stocks Poised for Breakouts
2013-05-31,4 Health Care Stocks Under $10 to Watch
2013-03-15,4 Biotech Stocks Under $5 to Watch
2013-03-04,Opexa Therapeutics To Present At The 6th Annual European Life Science CEO Forum
2013-02-07,Opexa Therapeutics, Inc. Announces Pricing Of Common Stock And Warrant Offering
2013-02-07,Opexa Therapeutics To Present At The 15th Annual BIO CEO &amp; Investor Conference
2013-02-05,Stocks Rebound Sharply; S&P 500, Nasdaq Rise Over 1%
2013-02-05,Investors Overreact to Opexa Finding Scant Interest for Failed Multiple Sclerosis Drug
2013-02-05,Merck Serono And Opexa Therapeutics Enter Into Option And License Agreement For Development Of Tcelna&#8482; (imilecleucel-T) For Treatment Of Multiple Sclerosis
2013-01-23,Opexa Therapeutics Closes Private Note Offering
2013-01-15,Opexa Therapeutics Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
2012-12-14,Opexa Therapeutics Announces Reverse Stock Split
2012-11-14,Opexa Therapeutics Reports Third Quarter 2012 Financial Results And Provides Corporate Update
2012-11-13,Opexa Receives Clinical Trial Approval From Health Canada For Novel T-Cell Therapy
2012-11-12,Opexa Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
2012-11-05,Opexa Announces Agreements For Up To $16.5 Million In Equity Commitments
2012-10-12,5 Stocks Poised for Breakouts
2012-10-02,Lessons From Biotech's Best Third Quarter Stocks
2012-09-17,Opexa To Participate At UBS Global Life Sciences Conference
2012-09-12,Opexa Initiates Late Stage Clinical Study Of Tcelna In Patients With Secondary Progressive Multiple Sclerosis (SPMS)
2012-09-10,Opexa To Participate At Upcoming Industry Conferences
2012-08-13,Opexa Therapeutics Reports Second Quarter 2012 Financial Results And Provides Corporate Update
2012-07-26,Opexa Therapeutics Closes Secured Note Financing
2012-05-21,Opexa Therapeutics Announces TcelnaTM As New Brand Name For MS Therapy
2012-05-11,Opexa Therapeutics Reports First Quarter 2012 Financial Results And Provides Corporate Update
2012-02-29,Opexa Therapeutics Executes Strategic Service Agreement With Pharmaceutical Research Associates To Manage Clinical Trial
2012-02-27,Opexa Therapeutics Reports Year End 2011 Financial Results And Provides Corporate Update
2012-02-08,Opexa Therapeutics To Present At The 14th Annual BIO CEO &amp; Investor Conference
2012-01-17,Opexa Therapeutics To Present At The BOCEMb; Noble Financial Capital Markets&#8217; Eighth Annual Equity Conference
2011-12-09,Opexa Therapeutics To Present At The Oppenheimer 22nd Annual Healthcare Conference
2011-11-14,Opexa Announces Publication In Multiple Sclerosis Journal Of Tovaxin&#174; Phase IIb Clinical Trial Results
2011-11-11,Opexa Therapeutics To Present At The Lazard Capital Markets 8th Annual Healthcare Conference
2011-11-08,Opexa&#8217;s Tovaxin&#174; For The Treatment Of Multiple Sclerosis Granted Fast Track Designation By FDA
2011-11-04,Opexa Therapeutics Reports Third Quarter 2011 Financial Results And Provides Corporate Update
2011-11-02,Opexa Elects Gail Maderis To Board Of Directors
2011-09-19,Opexa&#8217;s CEO Invited To Present At Two Cell Therapy Forums In Asia During September, 2011
2011-09-12,Dr. Mark Freedman To Join Opexa&#8217;s Scientific Advisory Board
2011-09-07,Opexa To Present At The Rodman &amp; Renshaw Annual Global Investment Conference - Healthcare On September 13, 2011
2011-08-11,Opexa Therapeutics Reports Second Quarter 2011 Financial Results And Provides Corporate Update
2011-06-28,Opexa Executes Service Agreement With Blood Group Alliance, Inc.
2011-06-02,Opexa Initiates Discussions With Health Canada In Pre-CTA Meeting
2011-05-17,Opexa Executes Strategic Service Agreement With The American Red Cross
2011-05-06,Opexa Therapeutics Reports First Quarter 2011 Financial Results
2011-04-20,Vista Partners Updates Coverage On Opexa Therapeutics, Inc.; Maintains Target Price Of $6.50
2011-04-15,Opexa Presents Tovaxin&#174; Data At American Academy Of Neurology 2011 Annual Meeting
2011-03-23,Opexa To Present Tovaxin&#174; Data At 2011 American Academy Of Neurology Annual Meeting
2011-03-08,Opexa Therapeutics Reports Year End 2010 Financial Results And Provides Corporate Update
2011-02-22,Opexa CEO Invited As Keynote Speaker At Cell Therapy Conference In Beijing, China
2011-02-09,Opexa To Present At The 13th Annual BIO CEO &amp; Investor Conference On February 14, 2011
2011-02-08,Opexa Therapeutics, Inc. Announces Pricing Of Public Offering Of&#160;Common&#160;Stock And Warrants
2011-02-07,Opexa Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock And Warrants
2011-01-07,Biotech Stock Mailbag: Best Stocks to Watch in '11
2011-01-05,Opexa Completes Successful Meetings With FDA To Pursue Phase 3 Clinical Study For Tovaxin&#174; In Multiple Sclerosis
2010-11-09,Opexa Therapeutics Reports Third Quarter 2010 Financial Results
2010-09-13,Otix Global, Entropic: Volume Movers
2010-09-08,Opexa To Present At The Rodman &amp; Renshaw 12th Annual Healthcare Conference On September 14, 2010
2010-08-06,Opexa Therapeutics Reports Second Quarter 2010 Financial Results
2010-08-05,Opexa Reconstitutes Scientific Advisory Board With Industry Leaders
2010-06-03,Opexa To Prepay Convertible Notes Issued In 2009
2010-05-13,Opexa Therapeutics Reports First Quarter 2010 Financial Results
2010-05-11,Opexa Strengthens Tovaxin&#174; Patent Estate Through Issuance Of Key Patents
2010-04-27,Opexa Strengthens Management Team With Hire Of Cell Therapy Expert
2010-04-14,Opexa Presents Tovaxin&#174; Data At The American Academy Of Neurology 2010 Annual Meeting
2010-04-09,Biotech Stock Mailbag: Vertex Pharma
2010-04-06,Opexa To Present Tovaxin&#174; Data At The American Academy Of Neurology 2010 Annual Meeting
2010-04-01,Opexa To Participate In Panel Discussion On Personalized Medicine For Multiple Sclerosis
2010-03-30,Versar, Opexa Therapeutics: Midday Volume Plays
2010-02-03,Opexa To Present At The 12th Annual BIO CEO &amp; Investor Conference On February 8, 2010
2009-09-23,YRC Worldwide: Pump Up the Volume
2009-09-11,Biotech Stock Mailbag: Genta Takes Another Stab
2009-09-09,Big Weight Loss for Vivus Drug: BioBuzz
2009-09-08,Biocryst Flu Drug Missing From CDC Guidelines: BioBuzz
2006-09-19,Tuesday's Health Winners & Losers
